PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+9.92%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$2.61B
AUM Growth
+$2.61B
(+2.1%)
Cap. Flow
-$23.8M
Cap. Flow
% of AUM
-0.91%
Top 10 Holdings %
Top 10 Hldgs %
32.6%
Holding
88
New
10
Increased
24
Reduced
13
Closed
7
Top Buys
| 1 |
Biogen
BIIB
|
$37.2M |
| 2 |
PNT
POINT Biopharma Global Inc. Common Stock
PNT
|
$34.9M |
| 3 |
Penumbra
PEN
|
$33.6M |
| 4 |
HCA Healthcare
HCA
|
$32.2M |
| 5 |
Prothena Corp
PRTA
|
$30M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$78M |
| 2 |
Pfizer
PFE
|
$70.4M |
| 3 |
Merck
MRK
|
$52.7M |
| 4 |
Becton Dickinson
BDX
|
$32.2M |
| 5 |
Universal Health Services
UHS
|
$32M |
Sector Composition
| 1 | Healthcare | 93.65% |
| 2 | Financials | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Myriad Genetics
MYGN
$593M
| $14.2M | 0.51% | 742,138 -435,112 | -37% | -$8.3M |
|
52
Werewolf Therapeutics
HOWL
$59.9M
| $12.7M | 0.46% | 2,815,654 +1,084,931 | +63% | +$4.89M |
|
53
Elevance Health
ELV
$71.8B
| $11.7M | 0.42% | 25,800 -16,934 | -40% | -$7.69M |
|
54
Outset Medical
OM
$247M
| $11.6M | 0.42% | +729,413 | New | +$11.6M |
|
55
iTeos Therapeutics
ITOS
| $10.2M | 0.37% | 537,954 | – | – |
|
56
PMV Pharmaceuticals
PMVP
$74.2M
| $10.2M | 0.37% | 855,164 -359,000 | -30% | -$4.27M |
|
|
ADAP
57
Adaptimmune Therapeutics
ADAP
$15.6M
| $10M | 0.36% | 9,320,584 +210,804 | +2% | +$227K |
|
|
JNCE
58
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $9.58M | 0.35% | 4,094,488 +144,820 | +4% | +$339K |
|
|
BPMC
59
DELISTED
Blueprint Medicines
BPMC
| $8.59M | 0.31% | +130,366 | New | +$8.59M |
|
60
Apellis Pharmaceuticals
APLS
$3.48B
| $8.32M | 0.3% | +121,880 | New | +$8.32M |
|
61
Praxis Precision Medicines
PRAX
$958M
| $7.85M | 0.28% | 3,458,525 +161,178 | +5% | +$366K |
|
|
CANO
62
DELISTED
Cano Health, Inc.
CANO
| $6.74M | 0.24% | +776,893 | New | +$6.74M |
|
63
IO Biotech
IOBT
$104M
| $5.85M | 0.21% | 2,159,155 | – | – |
|
|
BLSA
64
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
| $4.65M | 0.17% | 464,103 | – | – |
|
|
JYAC
65
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
| $4.63M | 0.17% | 464,103 | – | – |
|
|
ISEE
66
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $4.6M | 0.17% | 256,284 -649,732 | -72% | -$11.7M |
|
|
CMPS
67
Compass Pathways
CMPS
$424M
| $4.27M | 0.15% | 397,711 +4,947 | +1% | +$53.1K |
|
68
Sana Biotechnology
SANA
$777M
| $4.15M | 0.15% | 691,464 -261,269 | -27% | -$1.57M |
|
69
Pulmonx
LUNG
$69.7M
| $3.33M | 0.12% | +199,703 | New | +$3.33M |
|
70
ESSA Pharma
EPIX
$11.4M
| $2.69M | 0.1% | 1,478,252 +516,536 | +54% | +$940K |
|
71
SOPHiA GENETICS
SOPH
$234M
| $2.31M | 0.08% | 879,913 -886,149 | -50% | -$2.33M |
|
72
Sight Sciences
SGHT
$213M
| $1.45M | 0.05% | 227,692 -548,589 | -71% | -$3.48M |
|
73
Celcuity
CELC
$2.17B
| $1.41M | 0.05% | +140,426 | New | +$1.41M |
|
74
Zai Lab
ZLAB
$3.68B
| $808K | 0.03% | +23,612 | New | +$808K |
|
|
PRDS
75
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $528K | 0.02% | 285,170 -516,034 | -64% | -$955K |
|